tiprankstipranks
CERo Therapeutics Holdings (CERO)
NASDAQ:CERO
US Market

CERo Therapeutics Holdings (CERO) Financial Statements

Compare
376 Followers

CERo Therapeutics Holdings Financial Overview

CERo Therapeutics Holdings's market cap is currently $6.21M. The company's EPS TTM is $-43.791; its P/E ratio is ―; CERo Therapeutics Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -2.93M$ -2.91M$ -332.03K
EBITDA$ -2.44M$ -68.58K$ -332.03K
Net Income-$ -667.74K$ -315.55K
Balance Sheet
Cash & Short-Term Investments$ 96.87K$ 42.14M$ 1.10M
Total Assets$ 8.56M$ 42.37M$ 180.08M
Total Debt$ 1.55M$ 650.00K$ 3.60M
Net Debt$ 1.46M$ -41.49M$ 2.50M
Total Liabilities$ 22.76M$ 39.90M$ 9.25M
Stockholders' Equity$ -14.20M$ 2.47M$ 170.83M
Cash Flow
Free Cash Flow-$ -1.79M$ -1.31M
Operating Cash Flow-$ -1.09M$ -697.11K
Investing Cash Flow-$ 180.84M$ -178.50M
Financing Cash Flow-$ -138.70M$ 180.30M
Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History

CERo Therapeutics Holdings Debt to Assets

CERo Therapeutics Holdings Cash Flow

CERo Therapeutics Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis